APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nasal Flu Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nasal Flu Vaccine Industry Growth and Trends Forecast to 2032

2 January 202676 pages

Choose your research edition.

Industry ResearchNasal Flu Vaccine Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Nasal Flu Vaccine Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Nasal Flu Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nasal Flu Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Nasal Flu Vaccine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Nasal Flu Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nasal Flu Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nasal Flu Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nasal Flu Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nasal Flu Vaccine include AstraZeneca and Beike Bio among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nasal Flu Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nasal Flu Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nasal Flu Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nasal Flu Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nasal Flu Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nasal Flu Vaccine Market by Company

AstraZeneca

Beike Bio

Nasal Flu Vaccine Segment by Type

Trivalent Flu Vaccine

Quadrivalent Flu Vaccine

Nasal Flu Vaccine Segment by Application

Child

Adult

Nasal Flu Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nasal Flu Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nasal Flu Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nasal Flu Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nasal Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nasal Flu Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Trivalent Flu Vaccine Table 2. Major Company of Quadrivalent Flu Vaccine Table 3. Global Nasal Flu Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Nasal Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Nasal Flu Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Nasal Flu Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Nasal Flu Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Nasal Flu Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Nasal Flu Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Nasal Flu Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Nasal Flu Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Nasal Flu Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Nasal Flu Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Nasal Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Nasal Flu Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Nasal Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Nasal Flu Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Nasal Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Nasal Flu Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Nasal Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Nasal Flu Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Nasal Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Nasal Flu Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Nasal Flu Vaccine Industry Trends Table 25. Nasal Flu Vaccine Industry Drivers Table 26. Nasal Flu Vaccine Industry Opportunities and Challenges Table 27. Nasal Flu Vaccine Industry Restraints Table 28. Global Nasal Flu Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Nasal Flu Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Nasal Flu Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Nasal Flu Vaccine Sales Share by Company (2021-2026) Table 32. Global Nasal Flu Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Nasal Flu Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Nasal Flu Vaccine Major Company Production Sites and Headquarters Table 35. Global Nasal Flu Vaccine Company, Product Type & Application Table 36. Global Nasal Flu Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Nasal Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Nasal Flu Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Nasal Flu Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Nasal Flu Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Nasal Flu Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Nasal Flu Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Nasal Flu Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Nasal Flu Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Nasal Flu Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Nasal Flu Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Nasal Flu Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Nasal Flu Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Nasal Flu Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Nasal Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Nasal Flu Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Nasal Flu Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Nasal Flu Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Nasal Flu Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Nasal Flu Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Nasal Flu Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Nasal Flu Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Nasal Flu Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Nasal Flu Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Nasal Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Nasal Flu Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Nasal Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Nasal Flu Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Nasal Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Nasal Flu Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Nasal Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Nasal Flu Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Nasal Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Nasal Flu Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. AstraZeneca Company Information Table 72. AstraZeneca Business Overview Table 73. AstraZeneca Nasal Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AstraZeneca Nasal Flu Vaccine Product Portfolio Table 75. AstraZeneca Recent Development Table 76. Beike Bio Company Information Table 77. Beike Bio Business Overview Table 78. Beike Bio Nasal Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Beike Bio Nasal Flu Vaccine Product Portfolio Table 80. Beike Bio Recent Development Table 81. North America Nasal Flu Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 82. North America Nasal Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 83. North America Nasal Flu Vaccine Sales Market Share by Country (2021-2026) Table 84. North America Nasal Flu Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 85. North America Nasal Flu Vaccine Sales Market Share Forecast by Country (2027-2032) Table 86. North America Nasal Flu Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 87. North America Nasal Flu Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 88. North America Nasal Flu Vaccine Market Share by Country (2021-2026) Table 89. North America Nasal Flu Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 90. North America Nasal Flu Vaccine Market Share Forecast by Country (2027-2032) Table 91. Europe Nasal Flu Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. Europe Nasal Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 93. Europe Nasal Flu Vaccine Sales Market Share by Country (2021-2026) Table 94. Europe Nasal Flu Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 95. Europe Nasal Flu Vaccine Sales Market Share Forecast by Country (2027-2032) Table 96. Europe Nasal Flu Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. Europe Nasal Flu Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 98. Europe Nasal Flu Vaccine Market Share by Country (2021-2026) Table 99. Europe Nasal Flu Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. Europe Nasal Flu Vaccine Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Nasal Flu Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Nasal Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 103. Asia-Pacific Nasal Flu Vaccine Sales Market Share by Country (2021-2026) Table 104. Asia-Pacific Nasal Flu Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 105. Asia-Pacific Nasal Flu Vaccine Sales Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Nasal Flu Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Nasal Flu Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 108. Asia-Pacific Nasal Flu Vaccine Market Share by Country (2021-2026) Table 109. Asia-Pacific Nasal Flu Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Asia-Pacific Nasal Flu Vaccine Market Share Forecast by Country (2027-2032) Table 111. Latin America Nasal Flu Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Latin America Nasal Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 113. Latin America Nasal Flu Vaccine Sales Market Share by Country (2021-2026) Table 114. Latin America Nasal Flu Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 115. Latin America Nasal Flu Vaccine Sales Market Share Forecast by Country (2027-2032) Table 116. Latin America Nasal Flu Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Latin America Nasal Flu Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 118. Latin America Nasal Flu Vaccine Market Share by Country (2021-2026) Table 119. Latin America Nasal Flu Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Latin America Nasal Flu Vaccine Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Nasal Flu Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Nasal Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 123. Middle East and Africa Nasal Flu Vaccine Sales Market Share by Country (2021-2026) Table 124. Middle East and Africa Nasal Flu Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 125. Middle East and Africa Nasal Flu Vaccine Sales Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Nasal Flu Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Nasal Flu Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 128. Middle East and Africa Nasal Flu Vaccine Market Share by Country (2021-2026) Table 129. Middle East and Africa Nasal Flu Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Middle East and Africa Nasal Flu Vaccine Market Share Forecast by Country (2027-2032) Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Nasal Flu Vaccine Distributors List Table 134. Nasal Flu Vaccine Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Nasal Flu Vaccine Image Figure 2. Global Nasal Flu Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nasal Flu Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Nasal Flu Vaccine Sales (2021-2032) & (K Units) Figure 5. Trivalent Flu Vaccine Image Figure 6. Global Trivalent Flu Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Quadrivalent Flu Vaccine Image Figure 8. Global Quadrivalent Flu Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Nasal Flu Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Nasal Flu Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Nasal Flu Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Nasal Flu Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Nasal Flu Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Nasal Flu Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Nasal Flu Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Nasal Flu Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Nasal Flu Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Nasal Flu Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Nasal Flu Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Nasal Flu Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Nasal Flu Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Child Image Figure 24. Global Child Sales YoY Growth (2021-2032) & (K Units) Figure 25. Adult Image Figure 26. Global Adult Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Nasal Flu Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Nasal Flu Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Nasal Flu Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Nasal Flu Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Nasal Flu Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Nasal Flu Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Nasal Flu Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Nasal Flu Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Nasal Flu Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Nasal Flu Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Nasal Flu Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Nasal Flu Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Nasal Flu Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Nasal Flu Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Nasal Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Nasal Flu Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Nasal Flu Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Nasal Flu Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Nasal Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Nasal Flu Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Nasal Flu Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Nasal Flu Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Nasal Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Nasal Flu Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Nasal Flu Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Nasal Flu Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Nasal Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Nasal Flu Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Nasal Flu Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Nasal Flu Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Nasal Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Nasal Flu Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Nasal Flu Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Nasal Flu Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Trivalent Flu Vaccine
  • Quadrivalent Flu Vaccine
Applications
  • Child
  • Adult
Companies covered
  • AstraZeneca
  • Beike Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nasal Flu Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nasal Flu Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nasal Flu Vaccine Market by Type
  6. 1.3.1 Trivalent Flu Vaccine
  7. 1.3.2 Quadrivalent Flu Vaccine
  8. 1.4 Global Nasal Flu Vaccine Market Size by Type
  9. 1.4.1 Global Nasal Flu Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Nasal Flu Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Nasal Flu Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Nasal Flu Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Nasal Flu Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Nasal Flu Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Nasal Flu Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Nasal Flu Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nasal Flu Vaccine Industry Trends
  2. 2.2 Nasal Flu Vaccine Industry Drivers
  3. 2.3 Nasal Flu Vaccine Industry Opportunities and Challenges
  4. 2.4 Nasal Flu Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nasal Flu Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Nasal Flu Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Nasal Flu Vaccine Price (2021-2026)
  4. 3.4 Global Nasal Flu Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nasal Flu Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Nasal Flu Vaccine Company, Product Type & Application
  7. 3.7 Global Nasal Flu Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nasal Flu Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nasal Flu Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nasal Flu Vaccine Tier 1, Tier 2, and Tier 3
4 Nasal Flu Vaccine Regional Status and Outlook
  1. 4.1 Global Nasal Flu Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nasal Flu Vaccine Historic Market Size by Region
  3. 4.2.1 Global Nasal Flu Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nasal Flu Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nasal Flu Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nasal Flu Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Nasal Flu Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nasal Flu Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nasal Flu Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nasal Flu Vaccine by Application
  1. 5.1 Nasal Flu Vaccine Market by Application
  2. 5.1.1 Child
  3. 5.1.2 Adult
  4. 5.2 Global Nasal Flu Vaccine Market Size by Application
  5. 5.2.1 Global Nasal Flu Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Nasal Flu Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Nasal Flu Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Nasal Flu Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Nasal Flu Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Nasal Flu Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Nasal Flu Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Nasal Flu Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca Nasal Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AstraZeneca Nasal Flu Vaccine Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 Beike Bio
  8. 6.2.1 Beike Bio Company Information
  9. 6.2.2 Beike Bio Business Overview
  10. 6.2.3 Beike Bio Nasal Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Beike Bio Nasal Flu Vaccine Product Portfolio
  12. 6.2.5 Beike Bio Recent Developments
7 North America by Country
  1. 7.1 North America Nasal Flu Vaccine Sales by Country
  2. 7.1.1 North America Nasal Flu Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nasal Flu Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Nasal Flu Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nasal Flu Vaccine Market Size by Country
  6. 7.2.1 North America Nasal Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nasal Flu Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Nasal Flu Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nasal Flu Vaccine Sales by Country
  2. 8.1.1 Europe Nasal Flu Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nasal Flu Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Nasal Flu Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nasal Flu Vaccine Market Size by Country
  6. 8.2.1 Europe Nasal Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nasal Flu Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nasal Flu Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nasal Flu Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Nasal Flu Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nasal Flu Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nasal Flu Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nasal Flu Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Nasal Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nasal Flu Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nasal Flu Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nasal Flu Vaccine Sales by Country
  2. 10.1.1 South America Nasal Flu Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nasal Flu Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Nasal Flu Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nasal Flu Vaccine Market Size by Country
  6. 10.2.1 South America Nasal Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nasal Flu Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Nasal Flu Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nasal Flu Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Nasal Flu Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nasal Flu Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nasal Flu Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nasal Flu Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Nasal Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nasal Flu Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nasal Flu Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nasal Flu Vaccine Value Chain Analysis
  2. 12.1.1 Nasal Flu Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nasal Flu Vaccine Production Mode & Process
  7. 12.2 Nasal Flu Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nasal Flu Vaccine Distributors
  10. 12.2.3 Nasal Flu Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst